Male Pattern Hair Loss: Causes, Diagnosis and Evidence-Based Care

Androgenetic alopecia is one of those conditions that gets seen constantly and worked up properly far less often. Patients turn up worried, often after years of oils and home remedies, and a fair number leave with little more than a shampoo recommendation. It deserves better, because the biology is well understood and the treatments work when they are matched to the right patient. Here is the clinical picture, kept practical.

What's happening at the follicle

Androgenetic alopecia (AGA) is androgen-driven hair loss in people who are genetically primed for it. The mechanism is progressive miniaturization. Under the influence of dihydrotestosterone (DHT), the more potent metabolite of testosterone, susceptible follicles spend less time in their active growth phase and shrink a little with each cycle. Thick terminal hairs give way to fine vellus ones, and eventually those stop covering the scalp at all.

It is gradual. It follows a recognisable pattern. And it is driven far more by inherited sensitivity than by anything the patient did or did not do, which is worth saying out loud, because most of them arrive convinced it was their fault.

More common, and earlier, than most assume

The old notion that South Asian men were somehow spared has not aged well. Indian data points the other way. One study in the International Journal of Trichology put AGA prevalence at roughly 16 percent of men in their twenties, climbing past 50 percent by the age of fifty. In a metro setting, a dermatology clinic sees a steady flow of men in their mid-twenties already sitting at Norwood grade 3. A closer look at hair loss in Mumbai reflects the same blend of genetics, stress and lifestyle that turns up across urban India.

One point worth flagging for anyone seeing these patients. Early-onset AGA, before thirty, has been linked in several Indian studies to insulin resistance and metabolic syndrome. So a young man presenting with aggressive thinning may earn a broader metabolic look, not just a scalp one.

Making the diagnosis

Most AGA is a clinical diagnosis. The pattern does much of the talking, with frontal and vertex thinning in men, staged on the Norwood-Hamilton scale. A pull test gives a feel for active shedding. Trichoscopy adds the detail, showing the hair-shaft diameter variation and miniaturization that confirm the picture. The step that gets skipped too often is ruling out the mimics. Iron deficiency, thyroid dysfunction and telogen effluvium can all masquerade as pattern loss, or sit on top of it, and those are reversible. A basic workup before committing to a long plan saves everyone trouble down the line.

What the evidence supports

Treatment is a ladder, not a single fix. Topical minoxidil and oral finasteride remain the two pillars with the strongest evidence behind them. Finasteride works by lowering DHT; minoxidil by stretching out the growth phase. Both need consistency, and both do most for patients who start early, before too many follicles are gone for good. Low-level laser therapy has a reasonable base as an adjunct. Regenerative options such as PRP and the newer growth-factor concentrates are increasingly used to support density, with promising but still-maturing data. None of them regrow a follicle that has already been lost, which is the real ceiling of medical therapy.

When a transplant enters the picture

Surgery comes in when follicles are truly gone and medical therapy alone will not bring the area back. A transplant redistributes the patient's own DHT-resistant donor hair into the thinned zones. It does not manufacture new hair, which makes candidacy a donor-area question above all else. It also works best once the loss has stabilised or is being held with medical treatment, so grafts are not placed around hair that is still on its way out. Expectations matter as much as technique here. A consultation at a clinic such as Kibo Clinics can assess donor density, stage the loss and work out whether surgery, medical therapy, or some combination of the two fits the individual case.

The most useful message to pass on to patients is a simple one. AGA is a medical condition with a genuine evidence base behind its treatment, not a vanity problem to be quietly endured. Caught early and assessed properly, it is one of the more manageable things that will walk through the door. As always, individual management should follow a proper clinical assessment rather than a general article.